BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 21764643)

  • 1. Prognostic factors in uterine sarcoma.
    Gadducci A
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):783-95. PubMed ID: 21764643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine sarcomas: a review.
    D'Angelo E; Prat J
    Gynecol Oncol; 2010 Jan; 116(1):131-9. PubMed ID: 19853898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging of uterine sarcomas.
    Tse KY; Crawford R; Ngan HY
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):733-49. PubMed ID: 21752716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
    Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
    Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone receptor expression in uterine sarcomas: prognostic and therapeutic roles.
    Ioffe YJ; Li AJ; Walsh CS; Karlan BY; Leuchter R; Forscher C; Cass I
    Gynecol Oncol; 2009 Dec; 115(3):466-71. PubMed ID: 19767065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine sarcomas.
    Mbatani N; Olawaiye AB; Prat J
    Int J Gynaecol Obstet; 2018 Oct; 143 Suppl 2():51-58. PubMed ID: 30306577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine sarcomas 2013.
    Sutton G
    Gynecol Oncol; 2013 Jul; 130(1):3-5. PubMed ID: 23769183
    [No Abstract]   [Full Text] [Related]  

  • 8. Uterine sarcomas.
    Punnonen R; Lauslahti K; Pystynen P; Kauppila O
    Ann Chir Gynaecol Suppl; 1985; 197():11-4. PubMed ID: 3863523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts in the imaging of uterine sarcoma.
    Tirumani SH; Ojili V; Shanbhogue AK; Fasih N; Ryan JG; Reinhold C
    Abdom Imaging; 2013 Apr; 38(2):397-411. PubMed ID: 22699695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERBB-2 gene overexpression and amplification in uterine sarcomas.
    Amant F; Vloeberghs V; Woestenborghs H; Debiec-Rychter M; Verbist L; Moerman P; Vergote I
    Gynecol Oncol; 2004 Dec; 95(3):583-7. PubMed ID: 15581967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
    D'Angelo E; Spagnoli LG; Prat J
    Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is vascular and lymphatic space invasion a main prognostic factor in uterine neoplasms with a sarcomatous component? A retrospective study of prognostic factors of 60 patients stratified by stages.
    Rovirosa A; Ascaso C; Ordi J; Abellana R; Arenas M; Lejarcegui JA; Pahisa J; Puig-Tintoré LM; Mellado B; Armenteros B; Iglesias X; Biete A
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1320-9. PubMed ID: 11955745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the treatment of sarcomas in gynecology.
    Lange SS; Novetsky AP; Powell MA
    Discov Med; 2014 Sep; 18(98):133-40. PubMed ID: 25227754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874).
    Reed NS; Mangioni C; Malmström H; Scarfone G; Poveda A; Pecorelli S; Tateo S; Franchi M; Jobsen JJ; Coens C; Teodorovic I; Vergote I; Vermorken JB;
    Eur J Cancer; 2008 Apr; 44(6):808-18. PubMed ID: 18378136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Uterine sarcomas: clinical and histopathological aspects. Report on 15 cases].
    Leung F; Terzibachian JJ; Aouar Z; Govyadovskiy A; Lassabe C
    Gynecol Obstet Fertil; 2008 Jun; 36(6):628-35. PubMed ID: 18538624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SATB2 Expression in Uterine Sarcoma: A Multicenter Retrospective Study.
    Le Page C; Almadani N; Turashvili G; Bataillon G; Portelance L; Provencher D; Mes-Masson AM; Gilks B; Hoang L; Rahimi K
    Int J Gynecol Pathol; 2021 Sep; 40(5):487-494. PubMed ID: 33720083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of patients with uterine sarcoma: a debated clinical challenge.
    Gadducci A; Cosio S; Romanini A; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial stromal sarcoma of uterus.
    Xue WC; Cheung AN
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):719-32. PubMed ID: 21820965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients.
    Abeler VM; Røyne O; Thoresen S; Danielsen HE; Nesland JM; Kristensen GB
    Histopathology; 2009 Feb; 54(3):355-64. PubMed ID: 19236512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.